Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable ...
NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...
Expanded CONNECT SCI Study data demonstrated unprecedented durable improvement in function, independence, and quality of life ...
From Dachshunds to large breeds, managing disc disease requires us to be masters of nuance, neurology, and owner psychology.
Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering ...
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore ...
Liverpool specialist nurse and Manchester Arena bombing survivor were on hand for advice as Tyrone undergoes physio after hit ...
The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular ...
NervGen Pharma ( ($TSE:NGEN) ) has shared an announcement. NervGen Pharma has reported significant advancements in its CONNECT SCI Study, ...
Beneath the surface of your gut lies a vast network of neurons—as many as in your spinal cord. New research from the ...
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in communication, behavior and ...
One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback